PURPOSE OF REVIEW: An understanding of the current state of the antiretroviral marketplace is an important context in which to consider drug optimization work. RECENT FINDINGS: The antiretroviral marketplace has undergone a remarkable evolution over the past 11 years, expanding from serving less than 300 000 patients in low and middle-income countries in 2002 to almost 10 million patients today. In addition to dramatic growth, a steady and rapid improvement in the drugs and drug regimens used to treat patients has characterized a rapidly changing market. SUMMARY: The antiretroviral marketplace has been characterized by rapid growth and a succession of improving drugs and regimens over the past 11 years. The dynamic and innovative marketplace provides a strong platform from which to introduce new, optimized drugs and regimens to better serve patients' health needs.
PURPOSE OF REVIEW: An understanding of the current state of the antiretroviral marketplace is an important context in which to consider drug optimization work. RECENT FINDINGS: The antiretroviral marketplace has undergone a remarkable evolution over the past 11 years, expanding from serving less than 300 000 patients in low and middle-income countries in 2002 to almost 10 million patients today. In addition to dramatic growth, a steady and rapid improvement in the drugs and drug regimens used to treat patients has characterized a rapidly changing market. SUMMARY: The antiretroviral marketplace has been characterized by rapid growth and a succession of improving drugs and regimens over the past 11 years. The dynamic and innovative marketplace provides a strong platform from which to introduce new, optimized drugs and regimens to better serve patients' health needs.
Authors: Karin van den Berg; Marion Vermeulen; Vernon J Louw; Edward L Murphy; Gary Maartens Journal: Transfusion Date: 2021-07-05 Impact factor: 3.337